Pfizer’s swoop for Allergan gets the $160 billion pharma tie-up into an exclusive club for M&A deals worth $100 billion or more. FN counts down the blockbuster deals that left advisers celebrating a huge payday, and gives a nod to some that failed to get over the finish line
Investment Banking
In Pictures: The $100bn M&A monsters
Pfizer’s swoop for Allergan gets the $160 billion pharma tie-up into an exclusive club for M&A deals worth $100 billion or more. FN counts down the blockbuster deals that left advisers celebrating a huge payday, and gives a nod to some that failed to get over the finish line
